Story perspectives

Ramaphosa Unveils R1.3bn HIV Injection for Women

6/7/2026

Summary

Story summary

Cyril Ramaphosa announced a R1.3 billion program to roll out Lenacapavir, an injectable HIV prevention drug.
Lenacapavir, a twice-yearly capsid inhibitor, achieved near-100% effectiveness in South African and Ugandan trials.
Phase one will start in 360 clinics across 24 districts, targeting one million young women and pregnant mothers by 2027.
Funding from the South African government and the Global Fund includes a licensing deal for cheap generic injections, aiding Africa’s 2040 local-production goal.

1 of 1

Story summary

Cyril Ramaphosa announced a R1.3 billion program to roll out Lenacapavir, an injectable HIV prevention drug.
Lenacapavir, a twice-yearly capsid inhibitor, achieved near-100% effectiveness in South African and Ugandan trials.
Phase one will start in 360 clinics across 24 districts, targeting one million young women and pregnant mothers by 2027.
Funding from the South African government and the Global Fund includes a licensing deal for cheap generic injections, aiding Africa’s 2040 local-production goal.